MELISSA RUDAWSKI: Open Payments
NPI 1134590748 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 36 payments from 11 companies in 2025. Trend: 2023 $647 · 2024 $673 · 2025 $1,809
Food & beverage: $1,809
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 3 | $507 |
| Abbott Laboratories | 10 | $316 |
| Novartis Pharmaceuticals Corporation | 12 | $194 |
| ENDOTRONIX, INC. | 1 | $156 |
| AstraZeneca Pharmaceuticals LP | 3 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| SCPHARMACEUTICALS INC. | 1 | $123 |
| PFIZER INC. | 1 | $119 |
| CVRx, Inc. | 1 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
Products named: BIOMONITOR, CARDIOMEMS, LEQVIO, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR, Kerendia, FUROSCIX, VYNDAQEL, Barostim Neo System.
Industry payments across NY — which companies pay providers there.
